The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
Open accessAbstract
Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%. We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“recent genetic studies have indicated a complex polygenic architecture involving hundreds of genetic variants that individually confer a minimal increase on the overall risk of developing the disorder (Purcell et al., 2009)”
From DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia (2021) · cites this paper as Purcell et al., 2009
In the citing paper
“Schizophrenia has a heritability of 60–80%, much of which is attributable to common risk alleles.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [5]
In the citing paper
“Much of the between-individual variation in risk is genetic, involving large numbers of common alleles,5 rare copy number variants (CNVs)6, and rare coding variants (RCVs)7,8.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [5]
In the citing paper
“we evaluated the effectiveness of the primary technical and genomic quality control parameters on the genome-wide inflation of test statistics using the lambda GC (median)5 and as necessary made the QC parameters more stringent until this value was between 1.0 and 1.4 (before inclusion of principal components as covariates) and/or between 1.0 and 1.15 after inclusion of PCA covariates.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [5]
In the citing paper
“The development of robust polygenic scores for several common diseases has been catalysed by more precise per-variant effect estimates from larger GWAS datasets, improved algorithms for combining information across millions of single-nucleotide polymorphisms, and large-scale biobanks that support score validation69,146,147.”
From A brief history of human disease genetics (2020) · cites this paper as [146]
In the citing paper
“Additive effects of genetic risk markers were documented in schizophrenia (Purcell et al., 2009) and in ADHD (Jain et al., 2011).”
From From early markers to neuro-developmental mechanisms of autism (2014) · cites this paper as Purcell et al., 2009
In the citing paper
“Undoubtedly, the phenotypic expression of rare high-penetrance alleles is modulated by other genetic factors, including rare variants, as well as common (polygenic) variation (Purcell et al., 2009) or epigenetic regulation (Hirasawa and Feil, 2010).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Purcell et al., 2009
In the citing paper
“and only about a third of that recently explained for schizophrenia (30)”
From Individual common variants exert weak effects on the risk for autism spectrum disorders (2012) · cites this paper as [30]
In the citing paper
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [4]
In the citing paper
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [4]
In the citing paper
“Similarly in humans, by taking all nominally significant SNPs rather than just the GWAS significant ones, it is possible to capture much more of the genetic variance than is explained by the highly significant loci73,74”
From Rare and common variants: twenty arguments (2012) · cites this paper as [73]
In the citing paper
“Indeed, the large-scale impact of large numbers of common variants may be a general feature of human complex traits 70–77”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [70]
In the citing paper
“Hypothesized genetic architectures consisting entirely of rare variants are inconsistent with the data for AD, ASD, BIP, and SCZ (as well as for multiple other complex biomedical diseases). 70–77”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [70]
In the citing paper
“Common variant SNP effects have been estimated to explain large proportions of the phenotypic heritability for a wide range of diseases: BIP and SCZ; 69,130 T1DM, T2DM, Crohn’s disease, rheumatoid arthritis, celiac disease, and coronary artery disease; 70,77 and continuous traits (height, intelligence, and body mass). 70,131,132”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Self-citationXV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance.
Fisher, R. A. (1919) · Transactions of the Royal Society of Edinburgh · doi:10.1017/s0080456800012163 · Cited by 4,387
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,714
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Personal genomes: The case of the missing heritability
Maher, B. (2008) · Nature · doi:10.1038/456018a · Cited by 1,737
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
Rare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,081
Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis
Painter, J. N., Anderson, C. A., Nyholt, D. R., Macgregor, S., Lin, J., Lee, S. H., Lambert, A., Zhao, Z. Z., Roseman, F., Guo, Q., et al. (2011) · Nature Genetics · doi:10.1038/ng.731 · Cited by 308
Pérez-Andreu, V., Roberts, K. G., Harvey, R. C., Yang, W., Cheng, C., Pei, D., Xu, H. Y., Gastier, J. M., Shuyu, E., Lim, J. Y.-S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2803 · Cited by 307
Genetics Factors in Major Depression Disease
Shadrina, M. I., Bondarenko, E. A., & Slominsky, P. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00334 · Cited by 348
Extremely low-coverage sequencing and imputation increases power for genome-wide association studies
Pasaniuc, B., Rohland, N., McLaren, P. J., Garimella, K., Zaitlen, N., Li, H., Gupta, N., Neale, B. M., Daly, M. J., Sklar, P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2283 · Cited by 299
Genomics of disease risk in globally diverse populations
Gurdasani, D., Barroso, I., Zeggini, E., & Sandhu, M. S. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0144-0 · Cited by 312
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298
The Role of Immune System in Schizophrenia
Müller, N., & Schwarz, M. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823673 · Cited by 300
Zhao, B., Luo, T., Li, T., Li, Y., Zhang, J., Shan, Y., Wang, X., Yang, L., Zhou, F., Zhu, Z., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0516-6 · Cited by 295
Holmes, A. J., Lee, P. H., Hollinshead, M. O., Bakst, L., Roffman, J. L., Smoller, J. W., & Buckner, R. L. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2531-12.2012 · Cited by 293
“The genome-wide polygenic analyses, proposed by Purcell et al. (2009) consider the proportion of variation in disease risk explained through the additive effect of thousands of common variants.”
BackgroundInfluentialApplication of functional near-infrared spectroscopy in psychiatry
Ehlis, A., Schneider, S., Dresler, T., & Fallgatter, A. J. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.067 · Cited by 292
The Role of Genetics in the Etiology of Schizophrenia
Gejman, P. V., Sanders, A. R., & Duan, J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.003 · Cited by 312
Predicting Polygenic Risk of Psychiatric Disorders
Martin, A. R., Daly, M. J., Robinson, E., Hyman, S. E., & Neale, B. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.015 · Cited by 301
Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology
Sierksma, A., Lu, A., Mancuso, R., Fattorelli, N., Thrupp, N., Salta, E., Zoco, J., Blum, D., Buée, L., De Strooper, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910606 · Cited by 291
Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model
Wray, N. R., Wijmenga, C., Sullivan, P. F., Yang, J., & Visscher, P. M. (2018) · Cell · doi:10.1016/j.cell.2018.05.051 · Cited by 309
Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity
Hall, J., Trent, S., Thomas, K. L., O’Donovan, M. C., & Owen, M. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.011 · Cited by 290
Yue, W.-H., Wang, H.-F., Sun, L.-D., Tang, F.-L., Liu, Z.-H., Zhang, H.-X., Li, W.-Q., Zhang, Y.-L., Zhang, Y., Ma, C.-C., et al. (2011) · Nature Genetics · doi:10.1038/ng.979 · Cited by 289
So, H.-C., Gui, A. H. S., Cherny, S. S., & Sham, P. C. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20579 · Cited by 289
Zhang, Y., Qi, G., Park, J.-H., & Chatterjee, N. (2018) · Nature Genetics · doi:10.1038/s41588-018-0193-x · Cited by 288
The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry
Sullivan, P. F. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.003 · Cited by 285
The heritability of human disease: estimation, uses and abuses.
Tenesa, A., & Haley, C. S. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3377 · Cited by 283
Koshiyama, D., Fukunaga, M., Okada, N., Morita, K., Nemoto, K., Usui, K., Yamamori, H., Yasuda, Y., Fujimoto, M., Kudo, N., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0553-7 · Cited by 283
Hints of hidden heritability in GWAS
Gibson, G. (2010) · Nature Genetics · doi:10.1038/ng0710-558 · Cited by 281
Gatt, J. M., Burton, K., Williams, L. M., & Schofield, P. R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.014 · Cited by 281
Park, J.-H., Gail, M. H., Weinberg, C. R., Carroll, R. J., Chung, C. C., Wang, Z., Chanock, S. J., Fraumeni, J. F., & Chatterjee, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114759108 · Cited by 280
Multiethnic polygenic risk scores improve risk prediction in diverse populations
Márquez‐Luna, C., Loh, P., & Price, A. L. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22083 · Cited by 288
Williams, H. J., Norton, N., Dwyer, S., Moskvina, V., Nikolov, I., Carroll, L. S., Georgieva, L., Williams, N. M., Morris, D. W., Quinn, E. M., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.36 · Cited by 279
Genetics and epigenetics of eating disorders
Bulik, C., Yilmaz, Z., & HArdaway, A. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s55776 · Cited by 278
Advancing the use of genome-wide association studies for drug repurposing
Reay, W. R., & Cairns, M. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00387-z · Cited by 284
Schork, A., Thompson, W., Pham, P. H., Torkamani, A., Roddey, J., Sullivan, P., Kelsoe, J., O'Donovan, M., Furberg, H., Schork, N., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003449 · Cited by 320
Genetic Relationships Between Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder
Cardno, A. G., & Owen, M. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu016 · Cited by 294
Gene-environment interaction and psychiatric disorders: Review and future directions
Assary, E., Vincent, J. P., Keers, R., & Pluess, M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.10.016 · Cited by 295
The genetic architecture of economic and political preferences
Benjamin, D. J., Cesarini, D. A., van der Loos, M., Dawes, C. T., Koellinger, P., Magnusson, P. K. E., Chabris, C. F., Conley, D., Laibson, D., Johannesson, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120666109 · Cited by 283
Microbial genome-wide association studies: lessons from human GWAS
Power, R. A., Parkhill, J., & de Oliveira, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.132 · Cited by 285
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
Zhang, Q., Sidorenko, J., Couvy-Duchesne, B., Marioni, R. E., Wright, M. J., Goate, A. M., Marcora, E., Huang, K.-L., Porter, T., Laws, S. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18534-1 · Cited by 272
Voxelwise genome-wide association study (vGWAS)
Stein, J. L., Hua, X., Lee, S., Ho, A. J., Leow, A., Toga, A. W., Saykin, A. J., Shen, L., Foroud, T., Pankratz, N., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.032 · Cited by 276
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Li, P., Snyder, G. L., & Vanover, K. E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160608084834 · Cited by 279
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
Weng, L.-C. C., Preis, S. R., Hulme, O. L., Larson, M. G., Choi, S. H., Wang, B., Trinquart, L., McManus, D. D., Stærk, L., Lin, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031431 · Cited by 276
Random Forests for Genetic Association Studies
Goldstein, B. A., Polley, E. C., & Briggs, F. B. S. (2011) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1691 · Cited by 283
Shyn, S. I., Shi, J., Kraft, J. B., Potash, J. B., Knowles, J. A., Weissman, M. M., Garriock, H. A., Yokoyama, J. S., McGrath, P. J., Peters, E. J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.125 · Cited by 278
Extreme Polygenicity of Complex Traits Is Explained by Negative Selection
O'Connor, L. J., Schoech, A. P., Hormozdiari, F., Gazal, S., Patterson, N., & Price, A. L. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.07.003 · Cited by 268
The genetics of bipolar disorder
Gordovez, F. J. A., & McMahon, F. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0634-7 · Cited by 284
Convergence of placenta biology and genetic risk for schizophrenia
Ursini, G., Punzi, G., Chen, Q., Marenco, S., Robinson, J. F., Porcelli, A., Hamilton, E. G., Mitjans, M., Maddalena, G., Begemann, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0021-y · Cited by 276
Domingue, B. W., Belsky, D. W., Conley, D., Harris, K. M., & Boardman, J. D. (2015) · AERA Open · doi:10.1177/2332858415599972 · Cited by 265
Population structure in genetic studies: Confounding factors and mixed models
Sul, J. H., Martin, L. S., & Eskin, E. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007309 · Cited by 286
Autoimmune diseases, bipolar disorder, and non-affective psychosis
Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00853.x · Cited by 262
Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Alnæs, D., Kaufmann, T., van der Meer, D., Córdova‐Palomera, A., Rokicki, J., Moberget, T., Bettella, F., Agartz, I., Barch, D. M., Bertolino, A., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0257 · Cited by 265
MultiBLUP: improved SNP-based prediction for complex traitsPreprint
Speed, D., & Balding, D. J. (2014) · Genome Research · doi:10.1101/gr.169375.113 · Cited by 271
Sebat, J., Levy, D. L., & McCarthy, S. E. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.10.004 · Cited by 260
Immune aging, dysmetabolism, and inflammation in neurological diseases
Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260
The population genetics of mutations: good, bad and indifferent
Loewe, L., & Hill, W. G. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0317 · Cited by 226
European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI) (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu069 · Cited by 267
Personalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
A safe lithium mimetic for bipolar disorder
Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I. T., Sharp, T., Vasudevan, S. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms2320 · Cited by 259
Severance, E. G., Yolken, R. H., & Eaton, W. W. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.027 · Cited by 260
Family History of Schizophrenia and Bipolar Disorder as Risk Factors for Autism
Sullivan, P. F., Magnusson, C., Reichenberg, A., Boman, M., Dalman, C., Davidson, M., Fruchter, E., Hultman, C. M., Lundberg, M., Långström, N., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.730 · Cited by 266
Meyer, U., Schwarz, M., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 262
Andreassen, O. A., Hindley, G., Frei, O., & Smeland, O. B. (2023) · World Psychiatry · doi:10.1002/wps.21034 · Cited by 284
Beyond Missing Heritability: Prediction of Complex Traits
Makowsky, R., Pajewski, N. M., Klimentidis, Y. C., Vazquez, A. I., Duarte, C. W., Allison, D. B., & Campos, G. D. L. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002051 · Cited by 260
Weissbrod, O., Kanai, M., Shi, H., Gazal, S., Peyrot, W. J., Khera, A. V., Okada, Y., The Biobank Japan Project, Matsuda, K., Yamanashi, Y., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01036-9 · Cited by 262
Potential metabolite markers of schizophrenia
Yang, J., Chen, T., Sun, L., Zhao, Z., Qi, X., Zhou, K., Cao, Y., Wang, X., Qiu, Y., Su, M., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.131 · Cited by 251
Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H., Klauß, V., Schwarz, M., & Riedel, M. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 252
Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8881770 · Cited by 256
Talkowski, M. E., Mullegama, S. V., Rosenfeld, J. A., van Bon, B. W. M., Shen, Y., Repnikova, E. A., Gastier-Foster, J., Thrush, D. L., Kathiresan, S., Ruderfer, D. M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.011 · Cited by 249
BMES GWAS Group, Hysi, P. G., Cheng, C., Springelkamp, H., MacGregor, S., Bailey, J. N. C., Wojciechowski, R., Vitart, V., Nag, A., Hewitt, A. W., et al. (2014) · Nature Genetics · doi:10.1038/ng.3087 · Cited by 251
Discovery of shared genomic loci using the conditional false discovery rate approach
Smeland, O. B., Frei, O., Shadrin, A. A., O’Connell, K. S., Fan, C. C., Bahrami, S., Holland, D., Djurovic, S., Thompson, W. K., Dale, A. M., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02060-2 · Cited by 261
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13
Cho, M. H., Castaldi, P. J., Wan, E. S., Siedliński, M., Hersh, C. P., DeMeo, D. L., Himes, B. E., Sylvia, J. S., Klanderman, B. J., Ziniti, J. P., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr524 · Cited by 253
Severe Mental Disorders in Offspring With 2 Psychiatrically Ill Parents
Gottesman, I. I., Laursen, T. M., Bertelsen, A., & Mortensen, P. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.1 · Cited by 246
Contribution of Common Genetic Variants to Antidepressant Response
Tansey, K. E., Guipponi, M., Hu, X., Domenici, E., Lewis, G., Malafosse, A., Wendland, J. R., Lewis, C. M., McGuffin, P., & Uher, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.030 · Cited by 251
Hamshere, M. L., Walters, J., Smith, R. L., Richards, A. L., Green, E., Grozeva, D., Jones, I. R., Forty, L., Jones, L. A., Gordon‐Smith, K., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.67 · Cited by 247
Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
Rutten, B. P. F., & Mill, J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp104 · Cited by 244
Genetic basis of chronotype in humans: insights from three landmark GWAS
Kalmbach, D. A., Schneider, L. D., Cheung, J., Bertrand, S. J., Kariharan, T., Pack, A. I., & Gehrman, P. R. (2017) · Sleep · doi:10.1093/sleep/zsw048 · Cited by 243
GENDEP Investigators, MARS Investigators, STAR*D Investigators, Uher, R., Tansey, K. E., Henigsberg, N., Wolfgang, M. C., Mors, O. N., Hauser, J., Placentino, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020237 · Cited by 250
Copy number variation in schizophrenia in Sweden
Szatkiewicz, J., O'Dushlaine, C., Chen, G., Chambert, K., Moran, J. L., Neale, B. M., Fromer, M., Ruderfer, D. M., Akterin, S., Bergen, S. E., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.40 · Cited by 242
Arnedo, J., Švrakić, D. M., del Val, C., Romero‐Zaliz, R., Hernández‐Cuervo, H., Fanous, A. H., Pato, M. T., Pato, C. N., de Erausquin, G. A., Cloninger, C. R., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14040435 · Cited by 252
Meier, S. M., Trontti, K., Purves, K. L., Als, T. D., Grove, J., Laine, M., Pedersen, M. G., Bybjerg-Grauholm, J., Bækved-Hansen, M., Sokolowska, E., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1119 · Cited by 240
Bergen, S. E., O'Dushlaine, C. T., Ripke, S., Lee, P. H., Ruderfer, D. M., Akterin, S., Moran, J. L., Chambert, K. D., Handsaker, R. E., Backlund, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.73 · Cited by 244
Neurodevelopment, GABA System Dysfunction, and Schizophrenia
Schmidt, M. J., & Mirnics, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.95 · Cited by 243
Lin, M., Pedrosa, E., Shah, A., Hrabovsky, A., Maqbool, S. B., Zheng, D., & Lachman, H. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023356 · Cited by 247
Case–control association mapping by proxy using family history of disease
Liu, J. Z., Erlich, Y., & Pickrell, J. K. (2017) · Nature Genetics · doi:10.1038/ng.3766 · Cited by 238
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Gibney, S. M., & Drexhage, H. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9462-8 · Cited by 245
The synaptic hypothesis of schizophrenia version III: a master mechanism
Howes, O. D., & Onwordi, E. C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02043-w · Cited by 257
Predicting genetic predisposition in humans: the promise of whole-genome markers
Campos, G. D. L., Gianola, D., & Allison, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2898 · Cited by 240
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Li, A., Zalesky, A., Yue, W., Howes, O. D., Yan, H., Liu, Y., Fan, L., Whitaker, K. J., Xu, K., Rao, G., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0793-8 · Cited by 238
Frey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413478217 · Cited by 234
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Common variants on 8p12 and 1q24.2 confer risk of schizophrenia
Shi, Y., Li, Z., Xu, Q., Wang, T., Li, T., Shen, J., Zhang, F., Chen, J., Zhou, G., Ji, W., et al. (2011) · Nature Genetics · doi:10.1038/ng.980 · Cited by 239
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders
Heyes, S., Pratt, W. S., Rees, E., Dahimène, S., Ferron, L., Owen, M. J., & DOLPHIN, A. C. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.002 · Cited by 241
Jones, H. J., Stergiakouli, E., Tansey, K. E., Hubbard, L., Heron, J., Cannon, M. D., Holmans, P., Lewis, G., Linden, D. E. J., Jones, P. B., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3058 · Cited by 234
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Gassama, B., Sebastian, D., Buckley, P. F., & Mellor, A. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.007 · Cited by 232
Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F. F., Xiong, L., Piton, A., Spiegelman, D., Henrion, É., Millet, B., S2D team, et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.52 · Cited by 231
Keaton, J. M., Kamali, Z., Xie, T., Vaez, A., Williams, A., Goleva, S. B., Ani, A., Εvangelou, Ε., Hellwege, J. N., Yengo, L., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01714-w · Cited by 241
Whole-genome sequencing of a healthy aging cohort
Erikson, G. A., Bodian, D. L., Rueda, M., Molparia, B., Scott, E. R., Scott-Van Zeeland, A. A., Topol, S. E., Wineinger, N. E., Niederhuber, J. E., Topol, E. J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.022 · Cited by 202
How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete
Duncan, L. E., Ostacher, M. J., & Ballon, J. S. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0389-5 · Cited by 241
Holland, D., Frei, O., Desikan, R. S., Fan, C. C., Shadrin, A. A., Smeland, O. B., Sundar, V. S., Thompson, P. M., Andreassen, O. A., & Dale, A. M. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008612 · Cited by 239
Genomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 239
O'Dushlaine, C., Kenny, E., Heron, E., Donohoe, G., Gill, M., Morris, D., The International Schizophrenia Consortium, & Corvin, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.7 · Cited by 228
Doherty, J. L., & Owen, M. J. (2014) · Genome Medicine · doi:10.1186/gm546 · Cited by 228
How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis
Cannon, T. D. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.09.009 · Cited by 237
DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
Bettencourt, C., Hensman‐Moss, D., Flower, M., Wiethoff, S., Brice, A., Goizet, C., Stevanin, G., Koutsis, G., Karadima, G., Panas, M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24656 · Cited by 227
Integrated Neurobiology of Bipolar Disorder
Maletic, V., & Raison, C. L. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00098 · Cited by 236
Metadata
- Authors
- The International Schizophrenia Consortium
- Venue
- Nature
- Published
- 2009-07-01
- Volume
- 460
- Issue
- 7256
- Pages
- 748-752
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3912837
- OpenAlex
- W2098597355
- Cited by
- 4,821
- References
- 31
- Citations by year
- 2026: 84 · 2025: 129 · 2024: 190 · 2023: 235 · 2022: 246 · 2021: 291 · 2020: 354 · 2019: 337 · 2018: 297 · 2017: 339 · 2016: 365 · 2015: 328 · 2014: 316 · 2013: 330 · 2012: 348
- FWCI
- 197.43
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- Massachusetts Institute of Technology
- Wellcome Trust (066717)
- Broad Institute
- National Institute of Mental Health (R01MH077139, P50MH066392, R01MH071681, R01MH062137, R01MH074027, R01MH080403)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- schizophrenia, bipolar disorder, polygenic risk, common genetic variants, major histocompatibility complex, genetic susceptibility, immunity, heritability, psychiatric genetics
- MeSH terms
- Alleles, Bipolar Disorder, Europe, Female, Gene Frequency, Humans, Major Histocompatibility Complex, Male, Models, Genetic, Schizophrenia, Genetic Variation, Genome, Human, Case-Control Studies, Genetic Predisposition to Disease, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
